SCHEMBL6495356

SCHEMBL6495356

CC(NC(=O)C1CCN(C(=O)C=Cc2cc(C(F)(F)F)ccc2Cl)CC1)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 6/20 0.46
CAPN1 P07384 3/20 0.42
KMT2A Q03164 1/20 0.42
KCNH2 Q12809 2/20 0.41
ITGAL P20701 4/20 0.40
ITGB2 P05107 3/20 0.40
ICAM1 P05362 3/20 0.40
RORC P51449 1/20 0.40
TEAD1 P28347 2/20 0.39
EPHX2 P34913 1/20 0.39
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6495354 1.00 ENPP2 (0.46) ENPP2CAPN1KMT2AKCNH2ITGAL
SCHEMBL6497665 0.90 SMN1; SMN2 (0.48) ENPP2CAPN1KMT2AKCNH2ITGAL
SCHEMBL6497667 0.90 SMN1; SMN2 (0.48) ENPP2CAPN1KMT2AKCNH2ITGAL
SCHEMBL6504860 0.90 ENPP2 (0.46) ENPP2CAPN1KMT2AKCNH2ITGAL
SCHEMBL6503990 0.88 CAPN1 (0.45) ENPP2CAPN1KMT2AITGALITGB2
SCHEMBL6503994 0.88 CAPN1 (0.45) ENPP2CAPN1KMT2AITGALITGB2
SCHEMBL6508852 0.83 ITGAL (0.45) CAPN1KMT2AITGALITGB2ICAM1
SCHEMBL6508850 0.83 ITGAL (0.45) CAPN1KMT2AITGALITGB2ICAM1
SCHEMBL6503640 0.82 ITGAL (0.51) CAPN1KMT2AITGALITGB2ICAM1
SCHEMBL6503636 0.82 ITGAL (0.51) CAPN1KMT2AITGALITGB2ICAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed